Target intelligence / Profile preview

E3 ubiquitin-protein ligase RFWD3 (RFWD3)

Target
RFWD3
Molecular classification
Enzyme (E3 ubiquitin-protein ligase), DNA repair protein, RING finger protein
01

Overview

E3 ubiquitin-protein ligase RFWD3 is an enzyme that functions as a key regulator of DNA damage response and repair, particularly at stalled replication forks and double-strand breaks. It facilitates ubiquitination of several damage response proteins, including RPA, RAD51, and p53, which is critical for their removal from chromatin and subsequent repair by homologous recombination. RFWD3 is essential for maintaining genomic stability and protecting cells from DNA damage, and mutations in its gene cause Fanconi anemia complementation group W, a disorder marked by bone marrow failure and cancer susceptibility. RFWD3 is considered a promising therapeutic target due to its central role in DNA damage signaling and repair, especially in conditions where DNA repair mechanisms are compromised[1][2][3][4].

Other names
RING finger and WD repeat domain 3RNF201FLJ10520FANCWRING finger and WD repeat domain-containing protein 3RING finger protein 201RING-type E3 ubiquitin transferase RFWD3
02

Mechanism of action

Promotion of ubiquitination of target proteins at replication forks or DNA damage sites; Facilitation of removal of RPA and RAD51 to promote homologous recombination and resolution of DNA damage

03

Biological functions

DNA damage responseDNA repair, especially interstrand cross-link (ICL) repairHomologous recombination (HR)Regulation of cell cycle phase transition (G1/S checkpoint)Response to ionizing radiationUbiquitination of p53, RPA (Replication Protein A), RAD51, and PCNA (Proliferating Cell Nuclear Antigen)Translesion DNA synthesis
04

Disease associations

Fanconi anemia (complementation group W)Cancer predisposition (due to genome instability)Genomic instability syndromes
05

Safety considerations

Therapeutic targeting may affect DNA repair capacity, raising concerns for off-target toxicity or increased genomic instabilityPotential for bone marrow suppression if essential DNA repair processes are compromised
06

Biomarkers

RFWD3 mutations or protein levels as a biomarker for Fanconi anemia subgroup W and possibly for genome instability or DNA damage repair defects

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase RFWD3 (RFWD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase RFWD3 (RFWD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call